Formoterol 24 [mu]g is not associated with an increase in serious asthma exacerbations in patients with persistent asthma

The primary variable was percentage of patients reporting serious (e.g. requiring hospitalization) asthma-related adverse events (AEs).

Saved in:

Bibliographic Details
Published in:	Journal of allergy and clinical immunology Vol. 115; no. 2; p. S150
Main Authors:	Wolfe, J, LaForce, C, Ostrom, NK, Korenblat, P, Orevillo, C, Ziehmer, B, Till, D, Stenglein, S
Format:	Journal Article
Language:	English
Published:	St. Louis Elsevier Limited 01-02-2005
Subjects:	Drug therapy Medical research
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The primary variable was percentage of patients reporting serious (e.g. requiring hospitalization) asthma-related adverse events (AEs).
ISSN:	0091-6749 1097-6825
DOI:	10.1016/j.jaci.2004.12.611